Posterior reversible encephalopathy syndrome presenting with thrombotic microangiopathy triggered by malignant hypertension: a case report and literature review.
cerebral blood flow
haematology
headache
hypertensive encepha
thrombophilia
Journal
BMJ neurology open
ISSN: 2632-6140
Titre abrégé: BMJ Neurol Open
Pays: England
ID NLM: 101775450
Informations de publication
Date de publication:
2022
2022
Historique:
accepted:
07
08
2022
entrez:
14
9
2022
pubmed:
15
9
2022
medline:
15
9
2022
Statut:
epublish
Résumé
Posterior reversible encephalopathy syndrome (PRES) is a disease characterised by reversible subcortical vasogenic oedema, neurological symptoms and abnormal findings on head imaging. It is recognised as one of the most prominent organ disorders in hypertensive emergencies but is rarely associated with thrombotic microangiopathy (TMA). A woman in her 40s with untreated hypertension had occasional headaches in the past 4 months. The headaches worsened during the 3 weeks prior to admission. On the day of admission, the patient presented with severe headache accompanied by frequent vomiting. MRI of the head revealed oedematous changes in the brainstem, including the subcortical, cerebellum and pons. Fundus examination revealed hypertensive retinopathy with papilloedema. Blood tests indicated thrombocytopenia, renal dysfunction and haemolytic anaemia, and a blood smear confirmed fragmented erythrocytes. Coombs' test, and tests for ADAMTS13 activity and infectious and autoimmune diseases were negative. The patient was diagnosed with PRES, secondary to malignant hypertension (MH) and associated with TMA. Antihypertensive therapy promptly improved the clinical symptoms, blood pressure, and the abnormal MRI and blood test findings. The patient was discharged from the hospital 20 days after admission. We report a rare case of PRES that was associated with TMA and triggered by MH. Antihypertensive therapy was effective in alleviating the associated adverse clinical symptoms. Differentiation of underlying diseases is essential for early intervention, since treatment depends on factors causing TMA.
Sections du résumé
Background
UNASSIGNED
Posterior reversible encephalopathy syndrome (PRES) is a disease characterised by reversible subcortical vasogenic oedema, neurological symptoms and abnormal findings on head imaging. It is recognised as one of the most prominent organ disorders in hypertensive emergencies but is rarely associated with thrombotic microangiopathy (TMA).
Case presentation
UNASSIGNED
A woman in her 40s with untreated hypertension had occasional headaches in the past 4 months. The headaches worsened during the 3 weeks prior to admission. On the day of admission, the patient presented with severe headache accompanied by frequent vomiting. MRI of the head revealed oedematous changes in the brainstem, including the subcortical, cerebellum and pons. Fundus examination revealed hypertensive retinopathy with papilloedema. Blood tests indicated thrombocytopenia, renal dysfunction and haemolytic anaemia, and a blood smear confirmed fragmented erythrocytes. Coombs' test, and tests for ADAMTS13 activity and infectious and autoimmune diseases were negative. The patient was diagnosed with PRES, secondary to malignant hypertension (MH) and associated with TMA. Antihypertensive therapy promptly improved the clinical symptoms, blood pressure, and the abnormal MRI and blood test findings. The patient was discharged from the hospital 20 days after admission.
Conclusions
UNASSIGNED
We report a rare case of PRES that was associated with TMA and triggered by MH. Antihypertensive therapy was effective in alleviating the associated adverse clinical symptoms. Differentiation of underlying diseases is essential for early intervention, since treatment depends on factors causing TMA.
Identifiants
pubmed: 36101544
doi: 10.1136/bmjno-2022-000296
pii: bmjno-2022-000296
pmc: PMC9413191
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e000296Informations de copyright
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Hypertension. 2011 Mar;57(3):490-6
pubmed: 21263115
Med Hypotheses. 2014 May;82(5):619-22
pubmed: 24613735
Hypertension. 2001 May;37(5):1199-208
pubmed: 11358929
AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2179-90
pubmed: 17110690
PLoS One. 2012;7(3):e33029
pubmed: 22427934
AJNR Am J Neuroradiol. 2008 Jun;29(6):1043-9
pubmed: 18403560
Front Neurol. 2021 Oct 29;12:660373
pubmed: 34777191
Autoimmun Rev. 2015 Sep;14(9):830-6
pubmed: 25999210
J Clin Hypertens (Greenwich). 2011 Mar;13(3):205-11
pubmed: 21366852
Discov Med. 2012 May;13(72):375-83
pubmed: 22642919
N Engl J Med. 1996 Feb 22;334(8):494-500
pubmed: 8559202
Proc Natl Acad Sci U S A. 1994 May 24;91(11):5212-6
pubmed: 7515189
N Engl J Med. 2004 Nov 25;351(22):2310-7
pubmed: 15564546
J Hypertens. 2002 May;20(5):817-8
pubmed: 12011633
Lancet Neurol. 2015 Sep;14(9):914-925
pubmed: 26184985
J Cereb Blood Flow Metab. 2016 Mar;36(3):513-38
pubmed: 26661240
J Stroke Cerebrovasc Dis. 2012 Nov;21(8):915.e17-20
pubmed: 22418002
Am J Hypertens. 2007 Aug;20(8):900-6
pubmed: 17679041
N Engl J Med. 2014 Aug 14;371(7):654-66
pubmed: 25119611
Lancet. 2005 Mar 19-25;365(9464):1073-86
pubmed: 15781103
Hypertens Res. 1995 Jun;18(2):111-7
pubmed: 7584916
J Clin Apher. 2012;27(6):302-11
pubmed: 22927184
J Clin Immunol. 2021 Aug;41(6):1229-1240
pubmed: 33844127